The uncertain role of immunosuppressive agents in Sjögren's syndrome

Cleveland Clinic Journal of Medicine

Volumn 64, Issue 10, 1997, Pages 523-526

  Linardaki, Garifallia ^a   Moutsopoulos, H M ^a,b,c,d  

^a LAIKO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PILOCARPINE;

ADULT; CASE REPORT; CLINICAL TRIAL; DRUG CYTOTOXICITY; DRUG SAFETY; FEMALE; FLUSHING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOMA; NEPHROTOXICITY; REVIEW; SJOEGREN SYNDROME; SWEATING;

ADULT; CLINICAL TRIALS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA; PROGNOSIS; RECURRENCE; SJOGREN'S SYNDROME;

EID: 0030678597     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.64.10.523     Document Type: Article

References (19)

1. Austin HA, Klippel JH, Balow JE, et al. Therapy of lupus nephritis: controlled trial of prednisone and cytotoxic drugs. N Eng J Med 1986; 314:614-619.
2. Fauci AS, Haynes BF, Katz P. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98:76-85.
3. Tzioufas AG, Manoussakis MN, Costello R, Silis M, Papadopoulos IMM, Moutsopoulos HM. Cryoglobulinemia in autoimmune rheumatic diseases: evidence of circulating monoclonal cryoglobulins in patients with primary Sjögren's syndrome. Arthritis Rheum 1986; 29:1098-1104.
4. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36:340-347.
5. Dafni U, Tzioufas AG, Staikos P, Skopouli F, Moutsopoulos HM. The prevalence of Sjögren's syndrome in a close rural community. Ann Rheum Dis 1997;56:521-525.
6. Fox PC, Atkinson JC, Macynski AA, et al. Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia) Arch Intern Med 1991; 151:1149-1152.
7. Skopouli FN, Fox PC, Galanopoulou V, Atkinson JC, Jaffe ES, Moutsopoulos HM. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome. J Rheum 1991; 18:210-214.
8. Drosos AA, Skopouli FN, Costopoulos JS, Papadimitriou CS, Moutsopoulos HM. Cyclosporin A (CyA) in primary Sjögren's syndrome: a double blind study. Ann Rheum Dis 1986; 45:732-735.
9. Vlachoyiannopoulos PG, Moutsopoulos HM. Therapy of Sjögren's syndrome. Rheumatology in Europe 1995; 24:63-64.
10. Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheum 1995; 34:326-333
11. Skopouli FN, Jagiello P, Tsifetaki M, Moutsopoulos HM. Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol 1996; 14:555-558
12. Price EJ, Rigby SP, Clancy O, Venables PJW. A double blind placebo controlled trial of azathioprine in the treatment of primary Sjögren's syndrome.[Abstract]. Br J Rheum 1997; 36(suppl 1):24.
13. Manoussakis MN, Moutsopoulos HM. Antimalarials in Sjögren's syndrome - the Greek experience. Lupus 1996; 5 (suppl 1):28-530.
14. Moutsopoulos HM, Kordossis T. Sjögren's syndrome revisited: Autoimmune epithelitis. Br J Rheum 1996; 35:204-206.
15. Moutsopoulos HM, Balow JE, Lawley TJ, Stahl NI, Antonovych TT, Chused TM. Immune-complex glomerulonephritis in Sicca syndrome. Am J Med 1978; 64:955-960.
16. Tsokos M, Lazarou SA, Moutsopoulos HM. Vasculitis in primary Sjögren's syndrome. Histologic classification and clinical presentation. Am J Clin Pathol 1987; 87:26-31.
17. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in Sicca syndrome. Ann Intern Med 1978; 89:888-892.
18. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996; 39:767-772.
19. Moutsopoulos HM. Sjögren's syndrome: Future directions. J Rheumatol 1997; 24(Suppl 50:33-34.